Suppr超能文献

用于根除幽门螺杆菌的基于美丽决明子的三水合阿莫西林漂浮型生物黏附胃滞留微丸。

Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.

作者信息

Thombre Nilima A, Gide Paraag S

机构信息

a Department of Pharmaceutics , M.E.T.'s Institute of Pharmacy , Nasik , Maharashtra , India.

出版信息

Drug Deliv. 2016;23(2):405-19. doi: 10.3109/10717544.2014.916766. Epub 2014 May 28.

Abstract

CONTEXT

An oral dosage form containing floating bioadhesive gastroretentive microspheres forms a stomach-specific drug delivery system for the treatment of Helicobacter pylori.

OBJECTIVES

To prepare and evaluate controlled release floating bioadhesive gastroretentive chitosan-coated amoxicillin trihydrate-loaded Caesalpinia pulcherrima galactomannan (CPG)-alginate beads (CCA-CPG-A), for H. pylori eradication.

MATERIALS AND METHODS

CCA-CPG-A beads were prepared by ionotropic gelation, using 2(3) factorial design with quantity of drug, combination of CPG with sodium alginate and concentration of calcium chloride as variables. Beads facilitated mucoadhesion to gastric mucosa with floating nature caused by chitosan coating for wide distribution throughout GIT. Developed beads were evaluated for characteristics like beads size-morphology, entrapment efficiency, DSC, XRD, FTIR, swelling ratio, in vitro mucoadhesion, in vitro drug release, in vitro floating and in vitro H. pylori growth inhibition studies. CCA-CPG-A beads were studied in Wistar rats for in vivo gastric mucoadhesion, in vivo H. pylori growth inhibition studies using PCR amplification of isolated DNA, rapid urease test.

RESULT

Developed beads possess drug release of 79-92%, entrapment efficiency of 65-89%, mucoadhesion of 61-89%. In vivo mucoadhesion study showed more than 85% mucoadhesion of beads even after 7th hour. In vitro-in vivo growth inhibition study showed complete eradication of H. pylori.

DISCUSSION

CPG-alginate and chitosan in beads interacts with gastric mucosubstrate surface for prolonged gastric residence with floating bioadhesion mechanism for H. pylori eradication in rats.

CONCLUSION

Floating bioadhesive CCA-CPG-A beads offer a promising drug delivery system for H. pylori eradication at lower dose, reduced adverse effect and enhance bioavailability.

摘要

背景

一种含有漂浮生物黏附性胃滞留微球的口服剂型形成了一种用于治疗幽门螺杆菌的胃特异性给药系统。

目的

制备并评价用于根除幽门螺杆菌的控释漂浮生物黏附性壳聚糖包衣的载三水合阿莫西林的凤凰木半乳甘露聚糖(CPG)-海藻酸钠珠(CCA-CPG-A)。

材料与方法

采用离子交联法制备CCA-CPG-A珠,以药物用量、CPG与海藻酸钠的组合以及氯化钙浓度为变量进行2(3)析因设计。珠粒通过壳聚糖包衣促进对胃黏膜的黏附,并具有漂浮特性,可在整个胃肠道广泛分布。对制备的珠粒进行如下特性评价:珠粒大小-形态、包封率、差示扫描量热法(DSC)、X射线衍射法(XRD)、傅里叶变换红外光谱法(FTIR)、溶胀率、体外黏膜黏附性、体外药物释放、体外漂浮以及体外幽门螺杆菌生长抑制研究。在Wistar大鼠中研究CCA-CPG-A珠的体内胃黏膜黏附性、使用分离DNA的聚合酶链反应扩增和快速尿素酶试验进行的体内幽门螺杆菌生长抑制研究。

结果

制备的珠粒药物释放率为79 - 92%,包封率为65 - 89%,黏膜黏附性为61 - 89%。体内黏膜黏附性研究表明,即使在第7小时后,珠粒的黏膜黏附性仍超过85%。体外-体内生长抑制研究表明幽门螺杆菌被完全根除。

讨论

珠粒中的CPG-海藻酸钠和壳聚糖与胃黏膜底物表面相互作用,通过漂浮生物黏附机制延长胃内滞留时间,从而在大鼠中根除幽门螺杆菌。

结论

漂浮生物黏附性CCA-CPG-A珠提供了一种有前景的给药系统,可用于以较低剂量根除幽门螺杆菌、减少不良反应并提高生物利用度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验